No Data
Hims & Hers, LifeMD Shares Soar 20+% Amid Novo Nordisk Deal for Weight-Loss Drugs
Eli Lilly Stock Gets a Double Downgrade. Where Weight-Loss Drugs Go From Here. -- Barrons.com
Market Rally at Risk as Tariffs Damage Spreads. -2-
Why New Wegovy Deals Won't Restore Novo's Obesity Lead -- Heard on the Street -- WSJ
ELI LILLY Earnings Preview: Recent $LLY Insider Trading, Hedge Fund Activity, and More
Sector Update: Consumer Stocks Rise in Late Afternoon